PT  - JOURNAL ARTICLE
AU  - Alessi, Joao V
AU  - Ricciuti, Biagio
AU  - Jiménez-Aguilar, Elizabeth
AU  - Hong, Fangxin
AU  - Wei, Zihan
AU  - Nishino, Mizuki
AU  - Plodkowski, Andrew J
AU  - Sawan, Peter
AU  - Luo, Jia
AU  - Rizvi, Hira
AU  - Carter, Brett W
AU  - Heymach, John V
AU  - Altan, Mehmet
AU  - Hellmann, Matthew
AU  - Awad, Mark
TI  - Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status
AID  - 10.1136/jitc-2020-001007
DP  - 2020 Aug 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e001007
VI  - 8
IP  - 2
4099  - http://jitc.bmj.com/content/8/2/e001007.short
4100  - http://jitc.bmj.com/content/8/2/e001007.full
SO  - J Immunother Cancer2020 Aug 01; 8
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.